Vladimir Baranov

Vladimir Baranov is a Soviet born Canadian scientist and one of the original co-inventors of Mass cytometry technology...[1] He co-founded DVS Sciences[2] in 2004 (acquired by Fluidigm in 2014 and then renamed to Standard BioTools in 2022[3]) along with Dmitry Bandura,Scott D. Tanner and Olga Ornatsky.

Dr. Baranov, a senior scientist at MDS SCIEX, was a key member of the research team that developed and promoted the Dynamic Reaction Cell®, which remains today at the pinnacle of quadrupole ICP-MS technology.

In 2005, together with Scott D. Tanner and Dmitry Bandura, he began independently developing an ICP-TOF-MS based cytometer and became a researcher at the University of Toronto in March 2005.

[4] After securing ample funding by 2010 from various sources, including National Institutes of Health, Ontario Institute for Cancer Research (OICR), the Ministry of Research and Innovation, Ontario Centres of Excellence, Health Technology Exchange, and Genome Canada via the Ontario Genomics Institute,[5][6][7] and venture capital from 5 AM Ventures,[8] Vladimir and the DVS Sciences team successfully commercialized their technology, leading to the acquisition of DVS Sciences by Fluidigm in 2014[9] Baranov was a principal scientist at DVS Sciences (and then Fluidigm) developing instrumental concepts and algorithmics that advance the CyTOF® line of products.

He also and played a fundamental role in the development of the MaxPar line of metal-labeling reagents until his retirement in 2019.